European Union - English - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoietic stem cell transplantation - antineoplastic agents - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - suxamethonium chloride - solution for injection - 50mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - cyclophosphamide monohydrate - coated tablets - 50 milligram - cyclophosphamide

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - cyclophosphamide - pdr for soln for injection - 500 milligram - cyclophosphamide

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - cyclophosphamide - pdr for soln for injection - 1000 milligram - cyclophosphamide

Malta - English - Medicines Authority

baxter healthcare limited - cyclophosphamide - powder for solution for injection - cyclophosphamide 500 mg - antineoplastic agents

Malta - English - Medicines Authority

baxter healthcare limited - cyclophosphamide - powder for solution for injection - cyclophosphamide 1 g - antineoplastic agents

Malta - English - Medicines Authority

baxter healthcare limited - cyclophosphamide - coated tablet - cyclophosphamide 50 mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - cyclophosphamide monohydrate - oral tablet - 50mg